Kyntra Bio (KYNB) traded down -12.26 % during a 24 hours period ending at 01:19 AM Central Europe on Tuesday 27th. One Kyntra Bio stock can currently be bought for about USD 4.5 on popular exchanges. Current supply of Kyntra Bio stocks is 4.1 mn. Kyntra Bio has a current market capitalization of USD 18.6 mn and approximately USD 201.5 k worth of Kyntra Bio was traded on exchanges in the last 24 hours. Since last month end, Kyntra Bio has traded -34.57 % down. Simple moving average of last 200 days is at USD 7.22. The highest price of past 52 weeks was recorded at USD 11.39 on 11/07/2025. 52 weeks low was at USD 4.56 on 10/23/2026.
Here is how related stocks have performed in the past 24 hours:
Local Bounti (LOCL) traded up 1.06 % and now trades at USD 0.92. Current market capitalisation for Local Bounti is USD 22.2 mn.
Ckx Lands (CKX) traded down -0.28 % and now trades at USD 10.74. Current market capitalisation for Ckx Lands is USD 21.7 mn. Current price/earnings ratio for Ckx Lands is 7.47.
Big Digital Energy (BGDE) traded down -7.21 % and now trades at USD 3.65. Current market capitalisation for Big Digital Energy is USD 21.9 mn.
Context Therapeutics (CNTX) traded up 1.27 % and now trades at USD 0.24. Current market capitalisation for Context Therapeutics is USD 22 mn.
Heartbeam (BEAT) traded down -1.26 % and now trades at USD 0.41. Current market capitalisation for Heartbeam is USD 22.2 mn.
About Kyntra Bio
FibroGen, Inc. is a research-oriented pharmaceutical company concentrated on unveiling innovative therapeutic agents to address significant unresolved medical issues. As a global player, it operates in the Health Care sector, with Biotechnology as its specific industry.
